Fengbo Wu
Impact in
- Toxicology top 5%
- Molecular Biology top 10%
- Advanced biosensing and bioanalysis techniques
- Protein Degradation and Inhibitors
- Histone Deacetylase Inhibitors Research
Papers in
-
- Advanced biosensing and bioanalysis techniques 8
- RNA Interference and Gene Delivery 6
- Protein Degradation and Inhibitors 5
- Co-authors
- Gu He (23 shared papers)Chao Zhang (3 shared papers)Bo Han (9 shared papers)Xinrong Zhang (2 shared papers)Liang Ouyang (7 shared papers)Yang Li (6 shared papers)Chao Zhang (1 shared paper)Xin Wang (1 shared paper)
- Journals
- European Journal of Medicinal Chemistry (4 papers)Frontiers in Pharmacology (4 papers)International Journal of Molecular Sciences (3 papers)Journal of Medicinal Chemistry (3 papers)Analytical Biochemistry (3 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Fengbo Wu
64 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 116
- Toxicology 57
- Molecular Biology 836
- Microbiology 63
- Spectroscopy 165
- Organic Chemistry 274
Countries citing papers authored by Fengbo Wu
This map shows the geographic impact of Fengbo Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengbo Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengbo Wu more than expected).
Fields of papers citing papers by Fengbo Wu
This network shows the impact of papers produced by Fengbo Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengbo Wu. The network helps show where Fengbo Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Fengbo Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 134 | |
| 2 | 2022 | 132 | |
| 3 | 2023 | 89 | |
| 4 | 2020 | 69 | |
| 5 | 2019 | 65 | |
| 6 | 2016 | 61 | |
| 7 | 2013 | 56 | |
| 8 | 2015 | 52 | |
| 9 | 2021 | 52 | |
| 10 | 2005 | 50 | |
| 11 | 2002 | 49 | |
| 12 | 2018 | 47 | |
| 13 | 2018 | 46 | |
| 14 | 2018 | 46 | |
| 15 | 2002 | 45 | |
| 16 | 2018 | 44 | |
| 17 | 1992 | 44 | |
| 18 | 2006 | 39 | |
| 19 | 2004 | 39 | |
| 20 | 2002 | 39 |
About Fengbo Wu
Fengbo Wu is a scholar working on Molecular Biology, Organic Chemistry, Immunology, Cancer Research and Cell Biology, having authored 66 papers that have together received 1.9k indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (8 papers), RNA Interference and Gene Delivery (6 papers), Biotin and Related Studies (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Protein Degradation and Inhibitors (5 papers), Autophagy in Disease and Therapy (4 papers), Molecular Sensors and Ion Detection (4 papers) and Nanoplatforms for cancer theranostics (4 papers). The work is most often cited by research in Toxicology (57 citations), Molecular Biology (836 citations), Microbiology (63 citations), Spectroscopy (165 citations) and Organic Chemistry (274 citations). Fengbo Wu has collaborated with scholars based in China, United States and France. Frequent co-authors include Gu He, Chao Zhang, Bo Han, Xinrong Zhang, Liang Ouyang, Yang Li, Chao Zhang, Xin Wang, Yanyan Zhang and Wei Huang. Their work appears in journals such as European Journal of Medicinal Chemistry, Frontiers in Pharmacology, International Journal of Molecular Sciences, Journal of Medicinal Chemistry and Analytical Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.